Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first ...
As of September 23, 2025, Pyxis had 100% of available days for its MR product tankers fixed at an average estimated time charter equivalent (TCE) rate of $21,380 per day, along with 82% of available ...
Maroussi, Greece, March 5, 2026 – Pyxis Tankers Inc. (PXS), (the “Company”, “we”, “our”, “us” or “Pyxis Tankers”), an international diversified shipping company, today announced unaudited results for ...
Link: https://www.zacks.com/commentary/2767977/5-small-drug-stocks-to-buy-as-the-industry-shows-some-recovery The drug and biotech sector bounced back this month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results